The abstract is read at the publisher; the summary is JClub's.
28S rsRNA-CTC_L20 is upregulated in hypoxic PASMCs and pulmonary hypertension models and promotes PASMC proliferation, with knockdown mitigating SuHx-induced pulmonary hypertension and vascular remodeling.
- Why it matters: rsRNAs from rRNA are linked to disease biology, but their roles in pulmonary hypertension and hypoxia-driven vascular remodeling are not well defined.
- What they did: The study identified 28S rsRNA-CTC_L20 and tested its effects in hypoxic PASMCs and in SuHx-induced PH, then mapped a pathway where it maintains ketogenic enzyme mRNA stability via a CTGNNGG motif to modulate BHB production.
- The result: Increased BHB enhances PKM2 β-hydroxybutyrylation at K166, raising PKM2 activity and glycolysis to support proliferation, defining an rsRNA–BHB–PKM2 β-hydroxybutyrylation axis and suggesting 28S rsRNA-CTC_L20 as a therapeutic target.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.